Status:
UNKNOWN
Effect of High-Intensity Interval Training Compared to Hydrochlorothiazide on Ambulatory Blood Pressure
Lead Sponsor:
Anil Nigam
Conditions:
Hypertension,Essential
Exercise Activity
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
The number of persons with hypertension is increasing and with it the number of related cardiovascular events and related functional or cognitive declines. While studies have suggested that physical a...
Eligibility Criteria
Inclusion
- Age at consent ≥ 60 years;
- Systolic Blood pressure measured through BPtru™ between SBP ≥ 120 mmHg and \< 140 and or DBP ≥ 80 mmHg
- Being able to sign the informed consent form
Exclusion
- Considered "highly active" according to the International Physical Activity Questionnaire
- Practicing more than 20 min per week of High-Intensity Interval Training
- Use of antihypertensive medication
- Contraindication for the practice of intense physical activity
- Functional limitations related to the exercise test and to intensive training
- Cardiovascular pathology
- Atrial fibrillation
- Psychiatric or neurological disorder
- Renal failure
- MMSE score \< 26
- Persons benefiting of enhanced protection: persons deprived of their liberty by a judicial or administrative decision, persons staying in a health or social institution, adults under legal protection and patients in emergency situations.
- Diabetes
Key Trial Info
Start Date :
April 26 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 10 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04103411
Start Date
April 26 2018
End Date
January 10 2022
Last Update
September 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiovascular Prevention and Rehabilitation Center
Montreal, Quebec, Canada, H1T 1N6